Trial Profile
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Sep 2015
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine; Nausea
- Focus Registrational; Therapeutic Use
- Acronyms PREDICT
- Sponsors NuPathe
- 01 Sep 2015 Results published in Teva Pharmaceuticals media release.
- 14 Jul 2015 Results published in the Headache.
- 08 Aug 2013 Post-hoc analyses presented at the 2013 International Headache Congress (IHC), according to a NuPathe media release.